title: Clinical and arrhythmic outcomes after implantation of a defibrillator for primary prevention of sudden death in patients with post-myocardial infarction cardiomyopathy: The Survey to Evaluate Arrhythmia Rate in High-risk MI patients (SEARCH-MI).
abstract: OBJECTIVE
  To evaluate clinical and arrhythmic outcomes in post-infarction cardiomyopathy patients implanted with a defibrillator (ICD) for primary prevention of sudden death.
  
  
  RESULTS
  The SEARCH-MI registry is a European multi-centre, prospective, observational study enrolling patients after myocardial infarction, chronic left ventricular dysfunction and an ICD implanted for primary prevention of sudden death. Data on 556 patients with at least one recorded follow-up are presented. Survey to Evaluate Arrhythmia Rate in High-risk MI (SEARCH-MI) patients were sicker than those enrolled in MADIT-II with higher New York Heart Association class and left bundle branch block. Total mortality was 10.4%. Close to one-third (30%) of patients experienced episodes of sustained ventricular arrhythmia. One-quarter (23%) received at least one appropriate therapy and 10% inappropriate therapy. Gender (25% males vs. 5% females, P = 0.0009) and history of non-sustained ventricular tachycardia (24% with vs. 18% without P = 0.037) were predictive of appropriate ventricular therapy.
  
  
  CONCLUSIONS
  SEARCH-MI represents the current clinical management of post-MI patients with left ventricular dysfunction indicated to defibrillator implant for primary prevention. European routine clinical practice was influenced by landmark trials and guidelines which impacted on the implantation of cardiac resynchronization therapy in over 25% of such patients. Non-sustained ventricular tachycardia identifies subjects with a higher incidence of appropriate ICD therapy.
authors.affiliation: Cardiovascular Department, San Filippo Neri Hospital, Via Martinotti, 20, 00135 Roma, Italy. m.santini@rmnet.it
authors.forename: Massimo
authors.initials: M
authors.lastname: Santini
authors.forename: Maurizio
authors.initials: M
authors.lastname: Russo
authors.forename: Gianluca
authors.initials: G
authors.lastname: Botto
authors.forename: Maurizio
authors.initials: M
authors.lastname: Lunati
authors.forename: Alessandro
authors.initials: A
authors.lastname: Proclemer
authors.forename: Boris
authors.initials: B
authors.lastname: Schmidt
authors.forename: Ali
authors.initials: A
authors.lastname: Erdogan
authors.forename: Erhard
authors.initials: E
authors.lastname: Helmling
authors.forename: Werner
authors.initials: W
authors.lastname: Rauhe
authors.forename: Martin
authors.initials: M
authors.lastname: Desaga
authors.forename: Elisabetta
authors.initials: E
authors.lastname: Santi
authors.forename: Marc
authors.initials: M
authors.lastname: Messier
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Boriani
mesh_terms: D000368:Aged; D001145:Arrhythmias, Cardiac / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D016757:Death, Sudden, Cardiac / Q000209:etiology / Q000517:prevention & control*; D017147:Defibrillators, Implantable; D005060:Europe; D005260:Female; D019983:Guideline Adherence; D006306:Health Surveys; D006801:Humans; D015994:Incidence; D053208:Kaplan-Meier Estimate; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications*; D017063:Outcome Assessment, Health Care; D011446:Prospective Studies; D012042:Registries; D016896:Treatment Outcome; D018487:Ventricular Dysfunction, Left / Q000150:complications / Q000503:physiopathology